Duloxetine 60 mg for chronic low back pain: Post hoc responder analysis of double-blind, placebo-controlled trials
Journal of Pain Research Aug 12, 2017
Alev L, et al. – Researchers planned this study to investigate the predictors of response to duloxetine for chronic low back pain (CLBP). They concluded that early pain reduction was suggestive of an overall response. Compared to patients with isolated CLBP, patients with multiple painful sites had more benefit from duloxetine.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries